Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome

BACKGROUND—Inhaled nitric oxide (iNO) is a potential therapeutic agent for the management of acute respiratory distress syndrome (ARDS). Concerns remain, however, regarding the potential toxicity from iNO and/or its oxidative derivatives and methaemoglobinaemia.
AIMS—To determine the risk of toxicit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tang, S. F., Sherwood, M., Miller, O.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 1998
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1717756/
https://ncbi.nlm.nih.gov/pubmed/10193254
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak